Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

Stephen G. O'Brien, François Guilhot, Richard A. Larson, Insa Gathmann, Michele Baccarani, Francisco Cervantes, Jan J. Cornelissen, Thomas Fischer, Andreas Hochhaus, Timothy Hughes, Klaus Lechner, Johan L. Nielsen, Philippe Rousselot, Josy Reiffers, Giuseppe Saglio, John Shepherd, Bengt Simonsson, Alois Gratwohl, John M. Goldman, Hagop KantarjianKerry Taylor, Gregor Verhoef, Ann E. Bolton, Renaud Capdeville, Brian J. Druker

Research output: Contribution to journalArticlepeer-review

2902 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences